Serum N-acetyl-β-D-glucosaminidase activity in a genetic rat model of non-insulin-dependent diabetes mellitus

Hypertension Research

Volumn 20, Issue 3, 1997, Pages 193-199

  Uehara, Yoshio ^a   Hirawa, Nobuhito ^b   Kawabata, Yukari ^a   Numabe, Atsushi ^c   Nagoshi, Hiroshi ^a   Gomi, Tomoko ^b   Ikeda, Toshio ^b   Goto, Atsuo ^a   Toyo oka, Teruhiko ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Diabetes mellitus; Glucosuria; Insulin; Insulin sensitivity; N acetyl D glucosaminidase; Non insulin dependent diabetes mellitus; Proteinuria

Indexed keywords

GLUCOSE; IMIDAPRIL; INSULIN; N ACETYL BETA GLUCOSAMINIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC MODEL; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HEART WEIGHT; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE;

ACETYLGLUCOSAMINIDASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, TYPE 2; GLUCOSE; HEMODYNAMIC PROCESSES; IMIDAZOLES; IMIDAZOLIDINES; KIDNEY; KIDNEY FUNCTION TESTS; NITRIC OXIDE; ORGAN SIZE; RATS; RATS, INBRED STRAINS;

EID: 0030663915     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.193     Document Type: Article

References (24)

1. Welwood JM, Ellis BG, Price RG, Hammond K, Thompson AI, Jones NF: Urinary N-acetyl-β-D-glucosaminidase activities in patients with renal disease. Br Med J 1975; 3: 408-411.
2. Maruhn D: Evaluation of urinary enzyme pattern in patients with kidney disease and primary benign hypertension. Curr Probl Clin Biochem 1983; 309: 1213-1217.
3. Alderman MH, Melcher L, Dryer DE, Reidenberg MM: Increased excretion of urinary N-acetyl-β-D-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. N Engl J Med 1983; 309: 1212-1217.
4. Welman E, Selwyn AP, Peters TJ, Colbeck JF, Fox KM: Plasma lysosomal enzyme activity in acute myocardial infarction. Cardiovasc Res 1978; 12: 99-105.
5. Schmider RE, Rockstroh JK, Munch HG, Ruddel H, Schlebush H: Elevated serum activity of N-acetyl-β-glucosaminidase in essential hypertension: diagnostic value and reversal to normal values after antihypertensive therapy. Am J Kidney Dis 1991; 6: 638-648.
6. Nomura G, Sakai S, Sumie M, Tashiro H, Toshima H: Serum N-acetyl-β-D-glucosaminidase activity in a large population: a useful index of cardiovascular impairment. Jpn Circ J 1982; 68: 68-74.
7. Simon G, Altman S: Increased serum N-acelyl-β-D-glucosaminidase activity in human hypertension. Clin Exp Hypertens 1982; 4: 355-365.
8. Hashimoto R, Adachi H, Nishida H, Tsuruta M, Nomura G: Serum N-acetyl-β-D-glucosaminidase activity in predicting the development of hypertension. Hypertension 1995; 25: 1311-1314.
9. Nakayama N, Sato T, Asahi Y, Toide K, Yabuuchi Y: The insulin resistance in Otsuka Long-Evans Tokushima Fatty (OLETF), a new spontaneous NIDDM model rat strain, in Huh KB, Shinn SH, Kaneko T (eds): Insulin resistance in human disease. Amsterdam, Excerpta Medica, 1993, pp 389-392.
10. Kawano K, Hirashima T, Mori S, Natori T: OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 1994; 24(Suppl): S317-S320.
11. Hirashima T, Kawano K, Mori S, Matsumoto K, Natori T: A diabetogenic gene (ODB-1) assigned to the X-chromosome in OLETF rats. Diabetes Res Clin Pract 1995; 27: 91-96.
12. Kubo M, Kato J, Ochiai T, Ishida R: Pharmacological studies on (4S)-1-methyl-3-(2S)-2-[N-[(1S)-1-ethoxycarbonyl-3-phenylpropyl] amino] propionyl-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities. Jpn J Pharmacol 1990; 53: 201-210.
13. Teraishi Y, Fujii T: Antihypertensive effect of TA/6366, a new angiotensin-converting enzyme (ACE) inhibitor in two-kidney, one-clip and one-kidney, one-clip renovascular hypertensive rats. Med J Hiroshima Univ 1991; 39: 437-446.
14. Friedman M, Freed SC: Microphonic manometer for indirect determination of systemic blood pressure in rats. Proc Soc Exp Biol Med 1946; 70: 670-672.
15. Green LC, Wagne DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and (15N)nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
16. Noto A, Ogawa Y, Mori S, et al: Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem 1983; 29: 1713-1716.
17. Horak E, Hopfer SM, Sunderman FW Jr: Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity. Clin Chem 1981; 27: 1180-1185.
18. Uehara Y, Hirawa N, Kawabata Y, et al: Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension 1994; 24: 770-778.
19. Raij J, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137-143.
20. Hirawa N, Uehara Y, Kawabata Y, et al: Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats. J Hypertens 1994; 12: 909-918.
21. Uehara M, Kishikawa H, Isami S, et al: Effect of insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 1994; 37: 300-307.
22. Raccah D, Pettenuzzo-Mollo M, Provendier O, et al on behalf of the CaptISM study group: Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. Am J Hypertens 1994; 7: 731-738.
23. Gavras I: Bradykinin-mediated effects of ACE inhibition. Kidney Int 1992; 42: 1020-1029.
24. Iimura O, Shimamoto K, Nakagawa M, et al: Kinin does not contribute to the improvement of insulin sensitivity in delapril treated fructose fed rats. Am J Hypertens 1994; 8 (part 2): 181A (Abstract).